Recommendations on the use of a 3rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised

Downloads

ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised

This update contains no new information but is just editorial changes.

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date: 
25 March 2022
Last updated: 
29 April 2022
Publication type: 
Guideline
Intended audience: 
General public